Earnings NYSE Nasdaq 100 U.S. Tech Politics Science AI SEC Business Wall Street Energy Dow Jones Dividend Bitcoin (BTC) Markets NVIDIA (NVDA) Investing Economy S&P 500 China Donald Trump Fed World Crude Oil Tesla (TSLA) Money Inflation Gold Software Apple (AAPL) U.K. Wealth Entertainment Health Amazon (AMZN) Retail 3M (MMM) Real Estate Taxes Europe Natural Gas Elon Musk Microsoft (MSFT) Security Meta Platforms (META) Retirement Truist Financial Corp (TFC) Canada Current Boeing (BA) Options Jim Cramer Hedge Funds Insurance Tax Sports Live Google Economics Manufacturing Pharmaceuticals Cars Mining Costco (COST) Airlines Warren Buffett War Japan Silver Construction York Interest Rates Ukraine BlackRock (BLK) New York Holidays Kamala Harris Finance Goldman Sachs (GS) REITs Space Mortgage KeyCorp (KEY) Internet Walmart (WMT) Aerospace JPMorgan (JPM) Ethereum (ETH) Intel (INTC) Walt Disney (DIS) Enterprise OpenAI ChatGPT GBP USD Netflix (NFLX) Australia Boston Morgan Stanley (MS) IndiaMore +
Market Insider Market Insider
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

1 week Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC

Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Amgen (AMGN)

X       

3 days Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X       

3 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X       

5 days 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X       

6 days Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X       

7 days Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X       

1 week Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X       

1 week Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X       

1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X       

1 week Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X       

1 week Amgen sinks as Cantor flags issues with obesity drugYouTube X       

1 week Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X       

2 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X       

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X       

3 weeks Analyst Report: AMGEN Inc.Yahoo Finance X       

3 weeks Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance X       

3 weeks Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X       

3 weeks Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X       

3 weeks Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool X       

3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X       

3 weeks Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com X       

3 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X       

3 weeks First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

3 weeks Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat X       

4 weeks Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat X       

4 weeks Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X       

4 weeks Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X       

4 weeks Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

4 weeks Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor FitzgeraldMarketBeat X       

1 month Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc.MarketBeat X       

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X       

1 month Amgen (NASDAQ:AMGN) Price Target Raised to $383.00MarketBeat X       

1 month Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

1 month Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

1 month Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

More news +
Home | Contact
  • X

© 2024 Market Insider